108 related articles for article (PubMed ID: 9861270)
1. The Mectizan Donation Programme--a 10-year report.
Dull HB; Meredith SE
Ann Trop Med Parasitol; 1998 Apr; 92 Suppl 1():S69-71. PubMed ID: 9861270
[TBL] [Abstract][Full Text] [Related]
2. Mectizan as a stimulus for development of novel partnerships: the international organization's perspective.
Etya'alé DE
Ann Trop Med Parasitol; 1998 Apr; 92 Suppl 1():S73-7. PubMed ID: 9861271
[TBL] [Abstract][Full Text] [Related]
3. The Mectizan Donation Program (MDP).
Thylefors B
Ann Trop Med Parasitol; 2008 Sep; 102 Suppl 1():39-44. PubMed ID: 18718154
[TBL] [Abstract][Full Text] [Related]
4. The Mectizan Donation Program: 20 years of successful collaboration - a retrospective.
Colatrella B
Ann Trop Med Parasitol; 2008 Sep; 102 Suppl 1():7-11. PubMed ID: 18718147
[TBL] [Abstract][Full Text] [Related]
5. Ivermectin and onchocerciasis: is it all solved?
Hopkins AD
Eye (Lond); 2005 Oct; 19(10):1057-66. PubMed ID: 16304585
[TBL] [Abstract][Full Text] [Related]
6. Mectizan(®) procurement and delivery for onchocerciasis mass drug administration programmes.
Ogoussan KT; Hopkins A
Acta Trop; 2011 Sep; 120 Suppl 1():S173-6. PubMed ID: 20974105
[TBL] [Abstract][Full Text] [Related]
7. The NGDO Co-ordination Group for Onchocerciasis Control.
Haddad D
Ann Trop Med Parasitol; 2008 Sep; 102 Suppl 1():35-8. PubMed ID: 18718153
[TBL] [Abstract][Full Text] [Related]
8. The delivery of ivermectin (Mectizan).
Burnham G; Mebrahtu T
Trop Med Int Health; 2004 Apr; 9(4):A26-44. PubMed ID: 15078277
[TBL] [Abstract][Full Text] [Related]
9. Operational lessons from 20 years of the Mectizan Donation Program for the control of onchocerciasis.
Thylefors B; Alleman MM; Twum-Danso NA
Trop Med Int Health; 2008 May; 13(5):689-96. PubMed ID: 18419585
[TBL] [Abstract][Full Text] [Related]
10. Delivery systems and cost recovery in Mectizan treatment for onchocerciasis.
Amazigo U; Noma M; Boatin BA; Etya'alé DE; Sékétéli A; Dadzie KY
Ann Trop Med Parasitol; 1998 Apr; 92 Suppl 1():S23-31. PubMed ID: 9861264
[TBL] [Abstract][Full Text] [Related]
11. Control of onchocerciasis.
Boatin BA; Richards FO
Adv Parasitol; 2006; 61():349-94. PubMed ID: 16735169
[TBL] [Abstract][Full Text] [Related]
12. Economic evaluation of Mectizan distribution.
Waters HR; Rehwinkel JA; Burnham G
Trop Med Int Health; 2004 Apr; 9(4):A16-25. PubMed ID: 15078276
[TBL] [Abstract][Full Text] [Related]
13. Mectizan Donation Program: evaluation of a public-private partnership.
Peters DH; Phillips T
Trop Med Int Health; 2004 Apr; 9(4):A4-15. PubMed ID: 15078275
[TBL] [Abstract][Full Text] [Related]
14. Impact of ivermectin on illness and disability associated with onchocerciasis.
Tielsch JM; Beeche A
Trop Med Int Health; 2004 Apr; 9(4):A45-56. PubMed ID: 15078278
[TBL] [Abstract][Full Text] [Related]
15. Onchocerciasis control in Uganda.
Ndyomugyenyi R
World Health Forum; 1998; 19(2):192-5. PubMed ID: 9652221
[TBL] [Abstract][Full Text] [Related]
16. GlaxoSmithKline and Merck: private-sector collaboration for the elimination of lymphatic filariasis.
Gustavsen KM; Bradley MH; Wright AL
Ann Trop Med Parasitol; 2009 Oct; 103 Suppl 1():S11-5. PubMed ID: 19843393
[TBL] [Abstract][Full Text] [Related]
17. The challenge of establishing community-directed treatment with Mectizan in Uganda.
Okwero P
Ann Trop Med Parasitol; 1998 Apr; 92 Suppl 1():S171-4. PubMed ID: 9861290
[TBL] [Abstract][Full Text] [Related]
18. Onchodermatitis.
Murdoch ME
Curr Opin Infect Dis; 2010 Apr; 23(2):124-31. PubMed ID: 20071985
[TBL] [Abstract][Full Text] [Related]
19. [Ivermectin].
Boussinesq M
Med Trop (Mars); 2005; 65(1):69-79. PubMed ID: 15903082
[TBL] [Abstract][Full Text] [Related]
20. Health care at the end of the road: opportunities from 20 years of partnership in onchocerciasis control.
Haddad D; Cross C; Thylefors B; Richards FO; Bush S; Hopkins AD; Baker SK
Glob Public Health; 2008; 3(2):187-96. PubMed ID: 19288370
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
